CA9 and rectal cancer: In rectal cancer, a limited number of studies have reported CAIX expression analysed by immunohistochemistry in surgical specimens from patients undergoing primary surgery [15–17] or in baseline biopsy samples or surgical specimens from patients given neoadjuvant therapy [16, 18, 19].